To sum up, SLX can significantly improve peritoneal tissue thickening and inflammation, downregulate the expression of TGF-β1, Smad2, Smad3, and Smad7 in peritoneal tissue, and improve the progress of peritoneal fibrosis. This evidence concerns the gene SMAD2 and Peritoneal Fibrosis.